Institut Paoli-calmettes

This study tested if doctors could safely reduce the strength of antibiotics given to cancer patients with life-threatening sepsis, without harming survival. It compared this 'de-escalation' strategy to continuing the initial strong antibiotics. The goal was to see if using fewer…

This study tested if adding a 6-month course of the drug apalutamide to standard 'watchful waiting' (active surveillance) could help men with low-risk prostate cancer. Researchers wanted to see if the drug could slow the cancer's progression and delay the need for more invasive t…

This study tested the safety of a new, gentler transplant method for older adults or those who cannot have a standard bone marrow transplant for leukemia or related blood cancers. The approach uses a small, mismatched donor transplant but skips the strong drugs that suppress the …

This study evaluated a new urine test called VISIOCYT to see how well it detects bladder cancer compared to standard methods. Researchers tested 701 patients who were already scheduled for routine bladder exams, either for initial suspicion of cancer or for follow-up monitoring. …